Dr. Kevin Kayvan Zarrabi is a medical oncologist specializing in the diagnosis and treatment of genitourinary malignancies, with a focus on prostate, kidney, bladder, and testicular cancers. His clinical and research efforts center on advancing novel therapeutic strategies to improve outcomes for patients with these diseases. He has played an active role in early- and late-phase clinical trials, including investigator-initiated studies, evaluating next-generation therapies in genitourinary oncology.
At Jefferson, Dr. Zarrabi works closely with a multidisciplinary team of urologic oncologists, radiation oncologists, pathologists, and basic and translational scientists to bridge discoveries from the laboratory to the clinic. He also serves as co-leader of the Philadelphia Prostate Cancer Working Group, where he leads collaborative efforts in translational and epidemiological research aimed at understanding the biology of lethal prostate cancer and developing innovative therapeutic approaches.